FIGURE 2.

Basic information and patient characteristics according to the reports. (A) The annual distribution of donepezil combined with memantine administration related AEs reports from 2004 to 2023. (B) Country distribution of adverse events for donepezil combined with memantine administration, Darker colors represent a higher number of reports. (C) Gender ratio of male and female in reported events. (D) Occupational information ratio in reported events. (E) Age distribution ratio in reported events. (F) Ratio of outcomes in reported events. Visualization through proportional area map. Larger areas represent more reporters.